| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/17/2013 | US20130019339 Plant transcription factors |
| 01/17/2013 | US20130019334 Corn event mzdt09y |
| 01/17/2013 | US20130019328 Pepper hybrid ps11423123 |
| 01/17/2013 | US20130019326 Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Metabolic Disorders |
| 01/17/2013 | US20130018177 Production of Sialylated N-Glycans in Lower Eukaryotes |
| 01/17/2013 | US20130018176 Methods of producing hybridomas and monoclonal antibodies and antibodies produced thereby |
| 01/17/2013 | US20130018175 Single variable domain antibodies against ox40l, constructs and therapeutic use |
| 01/17/2013 | US20130018174 Polypeptide modification method for purifying polypeptide multimers |
| 01/17/2013 | US20130018089 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 01/17/2013 | US20130018088 Methods and compositions for anti-egfr treatment |
| 01/17/2013 | US20130018086 Sirnas targeting exon 10 of pyruvate kinase m2 |
| 01/17/2013 | US20130018085 iRNA Agents Targeting VEGF |
| 01/17/2013 | US20130018084 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 01/17/2013 | US20130018000 Recombinant filaggrin polypeptides for cell importation |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |
| 01/17/2013 | US20130017977 Microarray Synthesis and Assembly of Gene-Length Polynucleotides |
| 01/17/2013 | US20130017976 Methods and means for producing efficient silencing construct using recombinational cloning |
| 01/17/2013 | US20130017975 Single nucleotide polymorphism for predicting prognosis of hepatocellular carcinoma |
| 01/17/2013 | US20130017972 Method and compositions involving microrna |
| 01/17/2013 | US20130017965 Osteoarthritis biomarkers and uses thereof |
| 01/17/2013 | US20130017608 Methods of increasing yields of pleuromutilins |
| 01/17/2013 | US20130017597 Use of biological photoreceptors as directly light-activated ion channels |
| 01/17/2013 | US20130017596 Polycistronic Vector for Human Induced Pluripotent Stem Cell Production |
| 01/17/2013 | US20130017588 Recombinant microorganisms having increased ability to produce butanol and method of producing butanol using the same |
| 01/17/2013 | US20130017583 Methods for producing polyhydroxyalkanoate copolymer with high medium chain length monomer content |
| 01/17/2013 | US20130017581 Nucleic acid construct comprising pyripyropene biosynthetic gene cluster and marker gene |
| 01/17/2013 | US20130017580 Synthesis of Prazole Compounds |
| 01/17/2013 | US20130017578 Muteins of the bacteriophage lambda integrases |
| 01/17/2013 | US20130017575 Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity |
| 01/17/2013 | US20130017574 Methods and compositions for enhanced expression and secretion of proteins |
| 01/17/2013 | US20130017572 Codon modified polynucleotide sequences for enhanced expression in a host system |
| 01/17/2013 | US20130017571 Pullulanase Variants and Uses Thereof |
| 01/17/2013 | US20130017554 Sumo-specific affinity tag |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017251 Antibody Specific for Apolipoprotein and Methods of Use Thereof |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017224 Nucleic Acid Molecules Encoding Rantes, and Compositions Comprising and Methods of Using the Same |
| 01/17/2013 | US20130017223 Methods and compositions for delivery of nucleic acids |
| 01/17/2013 | US20130017217 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 01/17/2013 | US20130017210 Display of antibody fragments on virus-like particles of rna bacteriophages |
| 01/17/2013 | US20130017209 A-beta binding polypeptides |
| 01/17/2013 | US20130017204 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae |
| 01/17/2013 | US20130017195 Anti-folate receptor alpha antibodies and uses thereof |
| 01/17/2013 | DE102011107197A1 Use of a crosslinked sulfonated polymer to separate macromolecules from a solution derived from a biological source, where the crosslinked sulfonated polymer is optionally bonded to a scaffolding containing a sulfonated aryl moiety |
| 01/17/2013 | CA2851316A1 Genes and proteins for alkanoyl-coa synthesis |
| 01/17/2013 | CA2842104A1 Corn products and methods for their production |
| 01/17/2013 | CA2841824A1 Bacterial host strain expressing recombinant dsbc |
| 01/17/2013 | CA2841600A1 Mutant .beta.-glucosidase, enzyme composition for decomposing biomass, and method of producing sugar solution |
| 01/17/2013 | CA2841548A1 Sumoylation of serca2a and cardiovascular disease |
| 01/17/2013 | CA2841543A1 Stacked herbicide tolerance event 8264.42.32.1, related transgenic soybean lines, and detection thereof |
| 01/17/2013 | CA2841475A1 Identifying affinity-matured human antibodies |
| 01/17/2013 | CA2841451A1 Ischemic disease therapeutic agent |
| 01/17/2013 | CA2840460A1 Antibodies that bind to ox40 and their uses |
| 01/17/2013 | CA2837809A1 A transgenic system for reversibly immortalizing mammalian quiescent cells |
| 01/16/2013 | EP2546651A1 Modulator compounds of the drug resistance in epithelial tumour cells |
| 01/16/2013 | EP2546350A1 Process for producing koda using lemna paucicostata |
| 01/16/2013 | EP2546349A1 Methods for transforming eukaryotic algae |
| 01/16/2013 | EP2546348A1 Herbicide-resistant brassica plants and methods of use |
| 01/16/2013 | EP2546347A2 Glycoprotein composition from engineered galactose assimilation pathway in Pichia pastoris |
| 01/16/2013 | EP2546346A2 All-in-one sample preparation device and method |
| 01/16/2013 | EP2546345A1 DNA encoding polypeptide involved in biosynthesis of herboxidiene |
| 01/16/2013 | EP2546344A2 Primer and probe for detecting chlamydophilia caviae, as well as chlamydophilia caviae detection method using the same |
| 01/16/2013 | EP2546343A1 Novel lipoxygenases derived from lemna paucicostata |
| 01/16/2013 | EP2546342A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 01/16/2013 | EP2546341A1 Fc binding protein and method for producing same |
| 01/16/2013 | EP2546340A1 High expression promoter derived from kluyveromyces marxianus |
| 01/16/2013 | EP2546339A1 Mutated alkaline celluase |
| 01/16/2013 | EP2546337A1 Means for inhibiting the expression of protein kinase 3 |
| 01/16/2013 | EP2546331A1 Highly productive isopropyl alcohol-producing bacterium |
| 01/16/2013 | EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 01/16/2013 | EP2546267A1 Bacterial host strain expressing recombinant DsbC |
| 01/16/2013 | EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 01/16/2013 | EP2546263A2 High molecular weight recombinant silk or silk-like protein, and micro- or nanoscale spider-web fiber or spider-web-like fiber produced using the recombinant silk or silk-like protein |
| 01/16/2013 | EP2546262A1 Modifying the content of storage compounds in seeds by expression of a Class II HD-Zip transcription factor |
| 01/16/2013 | EP2546260A1 Live, oral vaccine for protection against shigella dysenteriae serotype 1 |
| 01/16/2013 | EP2545183A1 Production of single-stranded circular nucleic acid |
| 01/16/2013 | EP2545182A1 Polynucleotide molecules for gene regulation in plants |
| 01/16/2013 | EP2545177A1 Organism with altered carotenoid content and method of producing same |
| 01/16/2013 | EP2545176A1 Recombinant protein production in heterologous systems |
| 01/16/2013 | EP2545175A1 Female-specific insect expression system |
| 01/16/2013 | EP2545174A2 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 01/16/2013 | EP2545173A2 Antisense modulation of nuclear hormone receptors |
| 01/16/2013 | EP2545172A2 Methods of testing for intracellular pathogens |
| 01/16/2013 | EP2545171A1 Hjurp peptides and vaccines including the same |
| 01/16/2013 | EP2545170A1 Death associated protein 1 variants and use thereof for modulating autophagy |
| 01/16/2013 | EP2545168A1 Modified family 5 cellulases and uses thereof |
| 01/16/2013 | EP2545167A1 Polypeptide having diterpene synthase activity |
| 01/16/2013 | EP2545165A2 Mutated rep encoding sequences for use in aav production |
| 01/16/2013 | EP2545163A1 Method of selecting induced pluripotent stem cell |
| 01/16/2013 | EP2545080A2 Npp1 fusion proteins |
| 01/16/2013 | EP2545078A1 Pd-1 antibody |
| 01/16/2013 | EP2545076A1 Biological products: humanised agonistic anti-pd-1 antibodies |
| 01/16/2013 | EP2545069A1 Streptococcus thermophilus bacterium |
| 01/16/2013 | EP2545067A1 Bluetongue virus recombinant vaccines and uses thereof |
| 01/16/2013 | EP2544722A1 Method and composition for alveolar epithelial cell-specific nucleic acid nuclear import |
| 01/16/2013 | EP2544716A2 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 01/16/2013 | EP2474614A9 Dna fragment for improving translation efficiency, and recombinant vector containing same |
| 01/16/2013 | EP2463366A9 Novel glycosyltransferase, novel glycosyltransferase gene, and novel glycosyl donor compound |
| 01/16/2013 | CN1954078B Process for producing hydroxycarboxylic acid |